1. The role of miRNAs in the invasion and metastasis of cervical cancer.
    Jin-Yan Wang et al, 2019, Biosci Rep CrossRef
  2. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap‐binding protein
    Asiya Batool et al, 2019, J Cell Biochem CrossRef
  3. Inhibiting Mnk selectively targets cervical cancer via suppressing eIF4E-mediated β-catenin activation
    Weijia Zhang et al, 2019, The American Journal of the Medical Sciences CrossRef
  4. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice.
    Yao Liu et al, 0 CrossRef
  5. Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers
    Ella Lineham et al, 2017, Future Medicinal Chemistry CrossRef
  6. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling
    Kuilong Wang et al, 2020, Phytomedicine CrossRef
  7. The high‐risk HPV E6 proteins modify the activity of the eIF4E protein via the MEK/ERK and AKT/PKB pathways
    Vicente Morales‐Garcia et al, 2020, FEBS Open Bio CrossRef
  8. Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway


    Xingxing Su et al, 2020, OTT CrossRef
  9. High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors
    Alejandra García et al, 2021, Proc Natl Acad Sci USA CrossRef
  10. The expression and significance of p4E‐BP1/4E‐BP1 in prostate cancer
    Kai‐yun Wang et al, 2022, Clinical Laboratory Analysis CrossRef
  11. White spot syndrome virus directly activates mTORC1 signaling to facilitate its replication via polymeric immunoglobulin receptor-mediated infection in shrimp
    Pan-Pan Hong et al, 2022, PLoS Pathog CrossRef
  12. Opioids and Cancer: Current Understanding and Clinical Considerations
    Dhananjay Sah et al, 2024, Current Oncology CrossRef